FI50337C - Menetelmä sepelvaltimoa laajentavien 2-amino-adenosiinijohdannaisten v almistamiseksi. - Google Patents

Menetelmä sepelvaltimoa laajentavien 2-amino-adenosiinijohdannaisten v almistamiseksi.

Info

Publication number
FI50337C
FI50337C FI682384A FI238468A FI50337C FI 50337 C FI50337 C FI 50337C FI 682384 A FI682384 A FI 682384A FI 238468 A FI238468 A FI 238468A FI 50337 C FI50337 C FI 50337C
Authority
FI
Finland
Prior art keywords
preparing
coronary vasodilator
aminoadenosine
derivatives
aminoadenosine derivatives
Prior art date
Application number
FI682384A
Other languages
English (en)
Swedish (sv)
Other versions
FI50337B (fi
Inventor
Klaus Koch
Erich Fauland
Kurt Stach
Max Thiel
Wolfgang Schaumann
Karl Dietmann
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of FI50337B publication Critical patent/FI50337B/fi
Application granted granted Critical
Publication of FI50337C publication Critical patent/FI50337C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI682384A 1967-08-25 1968-08-23 Menetelmä sepelvaltimoa laajentavien 2-amino-adenosiinijohdannaisten v almistamiseksi. FI50337C (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEB0094161 1967-08-25

Publications (2)

Publication Number Publication Date
FI50337B FI50337B (fi) 1975-10-31
FI50337C true FI50337C (fi) 1976-02-10

Family

ID=6987386

Family Applications (1)

Application Number Title Priority Date Filing Date
FI682384A FI50337C (fi) 1967-08-25 1968-08-23 Menetelmä sepelvaltimoa laajentavien 2-amino-adenosiinijohdannaisten v almistamiseksi.

Country Status (11)

Country Link
US (1) US3590029A (fi)
JP (1) JPS4838719B1 (fi)
AT (3) AT282835B (fi)
CH (1) CH518951A (fi)
DE (1) DE1670265A1 (fi)
FI (1) FI50337C (fi)
FR (1) FR1587681A (fi)
GB (1) GB1164580A (fi)
IE (1) IE32299B1 (fi)
NL (1) NL6812083A (fi)
SE (1) SE349581B (fi)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4038479A (en) * 1969-11-17 1977-07-26 Burroughs Wellcome Co. Amino purine derivatives
US3887706A (en) * 1969-12-12 1975-06-03 Schering Ag N6-(3-Chlorobuten-2-yl)-adenosines as anti-inflammatory agents
DE2059922A1 (de) * 1970-12-05 1972-06-15 Boehringer Mannheim Gmbh Neue N(6)-Aralkyl-adenosin-Derivate und Verfahren zur Herstellung derselben
US4027026A (en) * 1971-03-09 1977-05-31 Smith Kline & French Laboratories Limited Pharmaceutical compositions and methods of inhibiting H-2 histamine receptors with pyridyl substituted thioalkyl- and oxyalkyl-thioureas and ureas
BE788958A (fr) * 1971-09-18 1973-03-19 Schering Ag Derives d'adenosine et leur procede de preparation
US4090021A (en) * 1971-10-08 1978-05-16 Schering Aktiengesellschaft Process for the production of N6 -substituted adenosine nucleotides and products resulting therefrom
BE789773A (fr) * 1971-10-08 1973-04-06 Schering Ag Adenosines n6 -substituees et leur procede de
DE2157036A1 (de) * 1971-11-17 1973-05-24 Boehringer Mannheim Gmbh Neue heterocyclisch substituierte nebularin-derivate und verfahren zu deren herstellung
DE2244328A1 (de) * 1972-09-09 1974-03-21 Boehringer Mannheim Gmbh Neue n(6)-disubstituierte adenosinderivate und verfahren zur herstellung derselben
DE2359536C2 (de) * 1972-12-08 1984-08-02 Takeda Chemical Industries, Ltd., Osaka 2,6-Diaminonebularinderivate
US4016262A (en) * 1973-08-01 1977-04-05 Boehringer Mannheim G.M.B.H. Therapeutic compositions and methods employing N(6)-disubstituted adenosine compounds
DE2338963A1 (de) * 1973-08-01 1975-02-13 Boehringer Mannheim Gmbh Neue n(6)-disubstituierte adenosinderivate und verfahren zur herstellung derselben
US3992531A (en) * 1973-12-26 1976-11-16 Abbott Laboratories 2-Substituted adenosine-5'-carboxylates in the treatment of anginal pain
US4171432A (en) * 1978-06-22 1979-10-16 Miles Laboratories, Inc. Flavin adenine dinucleotide-iodothyronine conjugates
JPS57171998A (en) * 1981-04-15 1982-10-22 Fujisawa Pharmaceut Co Ltd Adenosine derivative and its salt, preparation thereof and medicinal composition containing the same
CA1239397A (en) * 1983-08-01 1988-07-19 James A. Bristol N.sup.6-substituted adenosines
US4501735A (en) * 1983-12-05 1985-02-26 Warner-Lambert Company N6-(1- and 2-benzocycloalkyl) adenosines
DE3406533A1 (de) * 1984-02-23 1985-08-29 Boehringer Mannheim Gmbh, 6800 Mannheim Verwendung von adenosin-derivaten als antiallergica und arzneimittel, die diese enthalten
EP0300144A3 (en) * 1984-04-18 1989-09-27 Whitby Research Incorporated N-6 alkyl substituted adenosine derivatives as cardiac vasodilators
US5310731A (en) * 1984-06-28 1994-05-10 Whitby Research, Inc. N-6 substituted-5'-(N-substitutedcarboxamido)adenosines as cardiac vasodilators and antihypertensive agents
CA1254888A (en) * 1984-10-26 1989-05-30 Bharat Trivedi N.sup.6-bicycloadenosines
US4593019A (en) * 1984-10-26 1986-06-03 Warner-Lambert Company N6 -tricyclic adenosines
US4614732A (en) * 1984-10-26 1986-09-30 Warner-Lambert Company N6 -acenaphthyl adenosines and analogs thereof
AU579412B2 (en) * 1984-10-26 1988-11-24 Warner-Lambert Company N` - substituted adenosines
US4673670A (en) * 1985-09-05 1987-06-16 Warner-Lambert Company N6 -acenaphthyl adenosines and analogs thereof
US4954504A (en) * 1986-11-14 1990-09-04 Ciba-Geigy Corporation N9 -cyclopentyl-substituted adenine derivatives having adenosine-2 receptor stimulating activity
US5063233A (en) * 1986-11-14 1991-11-05 Ciba-Geigy Corporation N9 -cyclopentyl-substituted adenine derivatives useful as adenosine receptor agonists
JPH0723394B2 (ja) * 1986-11-27 1995-03-15 日本臓器製薬株式会社 新規アデノシン誘導体及び該化合物を有効成分として含有する医薬組成物
US4968697A (en) * 1987-02-04 1990-11-06 Ciba-Geigy Corporation 2-substituted adenosine 5'-carboxamides as antihypertensive agents
US5034381A (en) * 1988-01-07 1991-07-23 Ciba-Geigy Corporation 2-(substituted amino) adenosines as antihypertensives
US5032584A (en) * 1988-10-26 1991-07-16 G. D. Searle & Co. S-diastereomer of an n6 -((2-hydroxypropyl)aryl)adenosine and its medicinal uses
US5030624A (en) * 1988-10-26 1991-07-09 G. D. Searle & Co. R-diastereomer of an N6 -[(2-hydroxypropyl)aryl]adenosine and its medicinal uses
US4992535A (en) * 1988-10-26 1991-02-12 G. D. Searle & Co. Methods of making novel R and S diastereomers of N6 -[(2-hydroxypropyl)aryl]adenosines
US5391739A (en) * 1989-03-29 1995-02-21 Merrell Dow Pharmaceuticals Inc. Selective adenosine receptor agents
US5256650A (en) * 1989-03-29 1993-10-26 Merrell Dow Pharmaceuticals Inc. Selective adenosine receptor agents
DK62592D0 (fi) * 1992-05-14 1992-05-14 Novo Nordisk As
US5672588A (en) * 1992-05-20 1997-09-30 Novo Nordisk A/S Purine derivatives
GB9312853D0 (en) * 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
US5683989A (en) * 1993-12-17 1997-11-04 Novo Nordisk A/S Treatment of ischemias by administration of 2,N6 -substituted adenosines
US5591776A (en) * 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
US5922751A (en) * 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
WO1996018399A1 (en) * 1994-12-13 1996-06-20 Euro-Celtique, S.A. Aryl thioxanthines
EP0799040B1 (en) * 1994-12-13 2003-08-20 Euroceltique S.A. Trisubstituted thioxanthines
US6025361A (en) * 1994-12-13 2000-02-15 Euro-Celtique, S.A. Trisubstituted thioxanthines
US6166041A (en) * 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
US6075016A (en) * 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
US5864037A (en) * 1996-06-06 1999-01-26 Euro-Celtique, S.A. Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity
TWI229674B (en) 1998-12-04 2005-03-21 Astra Pharma Prod Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses
US6784165B1 (en) * 1999-11-23 2004-08-31 Aderis Pharmaceuticals, Inc. Treatment of heart rhythm disturbances with N6-substituted-5′-(N-substituted) carboxamidoadenosines
ATE322494T1 (de) * 2000-01-07 2006-04-15 Universitaire Instelling Antwe Purin derivate, ihre herstellung und verwendung
CZ294538B6 (cs) * 2002-12-30 2005-01-12 Ústav Experimentální Botaniky Akademie Vědčeské Re Substituční deriváty N6-benzyladenosinu, způsob jejich přípravy, jejich použití pro přípravu léčiv, kosmetických přípravků a růstových regulátorů, farmaceutické přípravky, kosmetické přípravky a růstové regulátory tyto sloučeniny obsahující
WO2004100964A1 (en) * 2003-04-24 2004-11-25 Aderis Pharmaceuticals, Inc. Method of treating atrial fibrillation or atrial flutter
US20050118262A1 (en) * 2003-09-17 2005-06-02 Jack Aurora Controlled release formulation
CZ2009298A3 (cs) * 2009-05-14 2010-11-24 Univerzita Palackého v Olomouci Substituované 6-benzylaminopurin ribosidy, jejich použití a farmaceutický prípravek tyto slouceniny obsahující
HUE035188T2 (en) * 2009-11-13 2018-05-02 Academia Sinica Adenosine A2A receptor and adenzoin transporter double acting compounds for the prevention and treatment of neurodegenerative diseases

Also Published As

Publication number Publication date
DE1670265A1 (de) 1971-01-28
IE32299L (en) 1969-02-25
US3590029A (en) 1971-06-29
AT282835B (de) 1970-07-10
IE32299B1 (en) 1973-06-13
AT292203B (de) 1971-08-25
FI50337B (fi) 1975-10-31
AT292202B (de) 1971-08-25
FR1587681A (fi) 1970-03-27
SE349581B (fi) 1972-10-02
CH518951A (de) 1972-02-15
GB1164580A (en) 1969-09-17
NL6812083A (fi) 1969-02-27
JPS4838719B1 (fi) 1973-11-19

Similar Documents

Publication Publication Date Title
FI50337C (fi) Menetelmä sepelvaltimoa laajentavien 2-amino-adenosiinijohdannaisten v almistamiseksi.
FI52460C (fi) Menetelmä linkomysiinijohdannaisten valmistamiseksi.
BG16329A3 (bg) Метод за получаване на нови1-фенокси-2-хидрокси-3- алкиламинопропани
SU505349A3 (ru) Способ получени нафтилалкиламинов
DK118820B (da) Analogifremgangsmåde til fremstilling af derivater af 5-nitro-2-furyl-isoxazoliner.
BG15577A3 (bg) Метод за получаване на нови 1,3,4-тиадиазолил- карбамиди
BG17579A3 (bg) Метод за получаване на имидазолиди - нови производни
FI50797C (fi) Menetelmä entsyymipitoisen pesuaineseoksen valmistamiseksi.
DK123868B (da) Analogifremgangsmåde til fremstilling af 3-hydroxycumarin-derivater.
BG17305A3 (bg) Метод за получаване на нови производни р-аминоалкил-бензолсулфон- амида
BG17802A3 (bg) Метод за получаване на диалиламиноалканоиламиди
FI49047C (fi) Tapa valmistaa 3-dimetyyli-sulfamoyylifenotiatsiinijohdannaisia.
FI46740C (fi) Menetelmä ferrotitaaniseosten valmistamiseksi.
BG16333A3 (bg) Метод за получаване на гама-цианбутиралдимини
BG17313A3 (bg) Метод за получаване на s-нитрофурилови ппроизводни
DK122076B (da) Analogifremgangsmåde til fremstilling af carbamater af hydroxymethylpyridinderivater.
FI46622C (fi) Menetelmä fibrinolysokinaasien valmistamiseksi.
FI45553C (fi) Menetelmä terapeuttisesti käytettävien 16-tiosubstituoitujen 9beta,10a lfa-pregneenien valmistamiseksi
BG17545A3 (bg) Метод за получаване на нови производни на бензолцулфонамида
FI46722C (fi) Menetelmä 1alfa-hydroksi-18-metyyli-5alfa-H-androstaanijohdannaisten v almistamiseksi.
BG17328A3 (bg) Метод за получаване на нови производни на тиазепина
BG15223A3 (bg) Метод за получаване на нови 5-нитрофурилови производни
FI45344C (fi) Menetelmä rifamysiini SV:n valmistamiseksi.
FI47186C (fi) Tapa valmistaa 3-sulfamyyli-4-halogeenibetsamidi-johdannaisia.
BG16742A3 (bg) Метод за получаване на 5-нитрофурилови производни